Thoroughly mining the existing scientific evidence is a critical first step for your product development program. Evidera’s team of researchers has decades of experience in evidence review and synthesis, from the most basic literature reviews to cutting-edge and complex methods that can extract useful information from even the most disparate sources. We publish our studies regularly and have completed 30+ studies that have been incorporated into regulatory or HTA submissions. We have also completed at least 20 literature reviews in nearly every major therapeutic area, including 70+ reviews in oncology, 50+ in neurology and 40+ in cardiovascular.
Evidera will help you gain an understanding and unlock the value of published and “grey” literature to:
Any of these tasks can be part of an ongoing “surveillance” of the literature.
Understand the relative effectiveness of a product or treatment via a quantitative assessment of the available literature.
Understand clinical, epidemiological and/or health economic evidence via a systematic or targeted qualitative review of the available literature.
Understand real-world outcomes by reviewing information from various social media sources, pharmacovigilance feeds, market intelligence updates, etc.
Facilitate more efficient literature searching by mapping themes in existing literature.
Conduct fast, focused epidemiology and safety literature reviews to meet internal/external evidence needs in just days.
Use targeted comparisons to overcome challenges of traditional methods for indirect treatment comparison without compromising validity of results. Click here for more info.